NCRI’s Groups will become networks of experts, which will drive change against strategic priorities. Led by a leadership group and…
Reimagining drug discovery, report summarises findings from Beyond the Horizon event
'NCRI has published a report outlining key points from the Beyond the Horizon: ‘Innovative cancer drug discovery’ event. The aim…
Guidelines for the inclusion of pathology in clinical trial protocols: SPIRIT-Path
'An international group of cancer researchers, led by the National Cancer Research Institute’s (NCRI) Cellular Molecular Pathology Initiative (CMPath), has…
Tool to drive collaboration in cancer and Covid-19 research launched
'The cancer and Covid-19 research dashboard is a public resource that lists research projects looking at the impact of Covid-19…
Cancer research funding data for pre-pandemic published
'NCRI has published new figures showing the amount of money spent on cancer research by NCRI Partners in the 12…
NCRI Annual Review 2020-21
'In a year dominated by the COVID-19 pandemic, NCRI has continued to have an impact on the advancement of cancer…
NCRI Annual Review 2020-21
'In a year dominated by the COVID-19 pandemic, NCRI has continued to have an impact on the advancement of cancer…
NCRI to offer new opportunities for early career researchers
'NCRI has created an Early Career Researcher Forum, which will enable early career researchers to build collaborative networks in their…
Fiona Driscoll appointed as Chair of the National Cancer Research Institute
'Fiona Driscoll has been appointed as Chair of the National Cancer Research Institute (NCRI). She will take up the role…
Yorkshire Cancer Research becomes NCRI Partner
'Yorkshire Cancer Research is the latest cancer research funder to join the NCRI Partnership. Yorkshire Cancer Research is an independent…
Myeloma UK joins NCRI Partnership
'The National Cancer Research Institute (NCRI) is delighted to announce that Myeloma UK, a UK cancer research charity focussing exclusively…
COVIDSurg gathers evidence on the safety of surgery during COVID-19
'The COVID-19 pandemic resulted in rapid reductions in elective surgery, including surgery as a treatment for head and neck cancer.…